Search - tctmd.com

Displaying 141 - 160 of 251

Sort: Relevancy | Date

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

News Daily News

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

Todd Neale

August 18, 2017

News Daily News

Costs Up, Usage Down: Hospitals Curtailed Use of CV Meds When Prices Soared

Todd Neale

August 15, 2017

News Daily News

Black Men Have Twofold Higher Risk of Dying From First CHD Event

Michael O'Riordan

July 10, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

News Daily News

Poor Prescription Adherence After Acute MI Continues to Vex Researchers

L.A. McKeown

June 30, 2017

Presentation

Primary PCI Outcomes in STEMI Patients Treated via Radial Access With Bivalirudin or Heparin

May 23, 2017

News Daily News

Large US Study Suggests Little Difference Between Bivalirudin and Heparin for Transradial Primary PCI

Todd Neale

May 22, 2017

$Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It$

News Conference News SCAI 2017

Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It

L.A. McKeown

May 19, 2017

News Daily News

Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin

Todd Neale

March 07, 2017

News Daily News

US Data Show Positive Trends in Cardiovascular Care, Though Opportunities for Progress Persist

Yael L. Maxwell

January 23, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Daily News

Statins Seem to Reduce Alzheimer’s Disease Risk, But Race/Ethnicity and Statin Type Matter

Todd Neale

December 14, 2016

News Daily News

With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab

Yael L. Maxwell

December 06, 2016

News Daily News

Tricky Population of Patients With A-fib Undergoing PCI Tackled in New Consensus Document

Todd Neale

November 29, 2016

News Daily News

Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

November 11, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

News Daily News

Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge

Todd Neale

October 18, 2016

News Daily News

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

L.A. McKeown

October 05, 2016

Advertisement

Evolocumab Not Cost-Effective at Current List Price

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

Costs Up, Usage Down: Hospitals Curtailed Use of CV Meds When Prices Soared

Black Men Have Twofold Higher Risk of Dying From First CHD Event

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Poor Prescription Adherence After Acute MI Continues to Vex Researchers

Primary PCI Outcomes in STEMI Patients Treated via Radial Access With Bivalirudin or Heparin

Large US Study Suggests Little Difference Between Bivalirudin and Heparin for Transradial Primary PCI

Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It

Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin

US Data Show Positive Trends in Cardiovascular Care, Though Opportunities for Progress Persist

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Statins Seem to Reduce Alzheimer’s Disease Risk, But Race/Ethnicity and Statin Type Matter

With No RCTs, Propensity-Score Matched Analysis Informs Choice Between Cangrelor and GPIs in the Cath Lab

Tricky Population of Patients With A-fib Undergoing PCI Tackled in New Consensus Document

Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge

STEMI Patients Far From PCI Centers Fare Well With Pharmacoinvasive Strategy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content